An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer (AXIOM)
Clinical trial NCT01697462 · COMPLETED
Trial details
- NCT number
- NCT01697462
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-07-01
- Primary completion
- 2012-12-01
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.